Allergopharma GmbH & Co. KG   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Reinbek Germany (1969)

Organization Overview

First Clinical Trial
2001
NCT00263926
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now